Concepedia
Statistics
Publications
2
Citations
48
H-Index
Active since
2018
Affiliations
AstraZeneca (United Kingdom)(Current)
Michael W. Moles is an author at AstraZeneca (United Kingdom).
Publications per year
2018–2024
AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
Emilio Cosimo, Anuradha Tarafdar, Michael W. Moles et al. · Clinical Cancer Research · 2018 · 32 citations · Full text
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma
Michael W. Moles, Henry Erdlei, Lutz Menzel et al. · Frontiers in Immunology · 2024 · 16 citations · Full text
1–2 of 2